Target intelligence / Profile preview

Dopaminergic neuron terminal

Molecular classification
Other
01

Overview

The **dopaminergic neuron terminal** is the specialized axonal ending of a neuron that synthesizes, stores, and releases the neurotransmitter dopamine into the synaptic cleft in response to electrical impulses[3][6]. These terminals contain key proteins for dopamine metabolism, including the dopamine transporter (DAT) for reuptake, vesicular monoamine transporters for storage, and enzymes such as tyrosine hydroxylase for synthesis[3][6]. They are functionally critical in multiple brain pathways that regulate movement, emotion, motivation, and cognition[2][3][6]. Degeneration of dopaminergic neuron terminals, especially in the substantia nigra, is a hallmark of Parkinson’s disease[2][6]. While many drugs act at these terminals, the term refers to a compartment, not a specific molecular entity.

Other names
dopamine axon terminaldopamine synaptic terminalDA terminal
02

Mechanism of action

Mechanisms generally involve modulation of dopamine synthesis, storage, release, or reuptake at the terminal. Examples: - Blockade of reuptake (e.g., via DAT inhibition by cocaine) - Triggering increased release (e.g., amphetamines) - Precursor supplementation (Levodopa boosts dopamine synthesis in terminals)

03

Biological functions

Dopamine neurotransmitter synthesisSynaptic dopamine releaseDopamine reuptake via dopamine transporter (DAT)Modulation of postsynaptic signaling
04

Disease associations

Neurodegenerative disease (notably Parkinson’s disease)Psychiatric disorders (e.g., addiction, schizophrenia, depression)
05

Safety considerations

Neurotoxicity from over-stimulation or terminal degeneration (as in Parkinson’s disease and stimulant toxicity)Side effects from drugs modulating dopaminergic terminals include movement disorders, psychiatric symptoms, potential cardiotoxicity
06

Interacting drugs

Levodopa (L-DOPA)

4 more in the full profile.

07

Biomarkers

Tyrosine hydroxylase (enzyme required for dopamine synthesis)Dopamine transporter (DAT)NURR1 (transcription factor for dopaminergic differentiation)GIRK2 (marker present in certain subsets of DA neurons)

Beyond the preview

Go deeper on Dopaminergic neuron terminal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopaminergic neuron terminal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call